Nobody downloaded yet

Biosimilar - Research Paper Example

Comments (0) Cite this document
Summary
The Emergence of Biosimilars Abstract Biosimilar drugs offer inexpensive alternatives to medication therapy. However, many factors must be considered regarding the safety of the patient, the efficacy of the biosimilar, and the general impact on society. This article discusses the therapeutic value of biosimilars, the biochemistry of the drugs, and the potential for biosimilars to effectively treat disease…
Download full paperFile format: .doc, available for editing
GRAB THE BEST PAPER94.6% of users find it useful
Biosimilar
Read TextPreview

Extract of sample
"Biosimilar"

Download file to see previous pages Although it is the hope that their introduction may lower the cost of such expensive medicinal products, there have been concerns over the introduction and manufacturing considerations, immunogenicity, degree of similarity of these complex drugs, and regulatory approaches to biosimilars around the world. In addition, of concern are arguments and techniques employed by pharmaceutical companies to advance or discredit biosimilars, as well as issues with post-marketing surveillance programs and their limitations. The issues associated with introduction of biosimilar medicines across a range of pharmacological indications are controversial, as well as differences between biopharmaceutical products not subjected to regulatory approval and regulatory approved medicines. There are rapid changes in licensing of biosimilars and regulatory approval. Non-transparent promotion of biosimilar products gives clinicians a need to be wary. Hopefully, widespread availability of biopharmaceutical products will be provided by biosimilar medicines (Roger, 2010). ...
The manufacture of a biopharmaceutical involves several isolation and purification steps, and the product is complex. In terms of safety and efficacy of the product, even minor changes in production can have serious implications, and these procedures are proprietary to the manufacturer of the originator product. Existing and future regulation should prevent inappropriate and automatic substitution of a biosimilar for a reference biopharmaceutical product, and biosimilars should not be brought to market using the same procedure applied to generics (Misra A, 2010). Living systems or organisms are used to produce biological products, medicines, and therapeutic agents. Because of their expensive cost, access to these life-saving biological products is limited. In the next few years, patents on the early biological products will soon expire. This will allow other biotech/biopharmaceutical companies to manufacture the generic versions of the biological products, which are referred to as biosimilar medicinal products by the European Medicine Agency of the European Union, or as follow-on biological products by the U.S. Food and Drug Administration. Increase in patients' access to the much-needed biological pharmaceuticals by competition of cost-effective follow-on biological products with equivalent efficacy and safety can cut down the costs. Evaluation of equivalence (similarity) between the biosimilar products and their corresponding innovator product is a great challenge for both the scientific community and regulatory agencies due to the complexity and heterogeneity of the molecular structure, complicated manufacturing process, different analytical methods, and possibility of severe ...Download file to see next pagesRead More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Biosimilar Research Paper Example | Topics and Well Written Essays - 1500 words”, n.d.)
Retrieved from https://studentshare.org/family-consumer-science/1417161-biosimilar
(Biosimilar Research Paper Example | Topics and Well Written Essays - 1500 Words)
https://studentshare.org/family-consumer-science/1417161-biosimilar.
“Biosimilar Research Paper Example | Topics and Well Written Essays - 1500 Words”, n.d. https://studentshare.org/family-consumer-science/1417161-biosimilar.
  • Cited: 0 times
Comments (0)
Click to create a comment or rate a document
CHECK THESE SAMPLES - THEY ALSO FIT YOUR TOPIC
Definitions
3 Pages(750 words)Essay
Byzantine Empire
10 Pages(2500 words)Essay
Organizational Behavior
5 Pages(1250 words)Essay
Biopharmaceuticals against Viral disease - development and pharmaceutical action
..., the production of a biopharmaceutical is no easy feat. It requires work on many different levels of expertise (Sekhon, 2010). Very broadly, the development of a biopharmaceutical vaccine to target viruses generally involves the following stages. There is production of a carrier system followed by inoculation of the target with the virus. Reproducibility and infectivity are eliminated and the virus fragment is then purified (Sekhon, 2010). One biopharmaceuticals have been manufactured, there is also the possibility of manufacturing biosimilars, which are other biopharmaceuticals with similar structure and function. This is a challenging task as slight changes in structure; composition etc may result in a large...
4 Pages(1000 words)Research Paper
Health care reform to address access
...in access to innovative medical therapies through innovation and biologics price competition. With the establishment of the legislation, FDA will be in a position to license biological products that are shown to be either biosimilar or interchangeable to reference product (Kaiser, 2014). The basic values that underlie the approach to solving the access to health care problems include; focusing on provisions to expand medical cover for individuals and families in the United States, enacting measures to control health care and related medical costs to make it affordable to all individuals in America, and continuous improvement health care delivery system. The stated values do not align to any specific political...
2 Pages(500 words)Essay
Genentech: After the Acquisition by Roche
...the expected results, thereby causing fall in Genentech share prices. In the technological environment also, Genentech has been facing problems, as its certain technical shortfalls in his drug manufacturing plant resulted in shortages of liquid form of Tamiflu, commonly used for the treatment of flu. (Palmer, 2014). Environmentally, Genentech has been exhibiting effective management, sizably reducing GHG emissions from its plants. “Between 2011 and 2012, Genentechs total scope 1 and 2 GHG emissions decreased by 5%.” (“Reducing Energy Use”, 2012). To further protect its interests, Genentech have been in the forefront of sponsoring a legislation, which “would prevent pharmacists from being allowed to swiftly substitute a less expensive...
3 Pages(750 words)Essay
Module 3 SLP
3 Pages(750 words)Assignment
Pfizer
...its main competencies that the organization perceives as their best abilities to deliver novel products suiting the needs of the patients. Biosimilars The term Biosimilars is even used to refer to follow-on biologics that are products that fall in the category of biologic medicine. These products are developed with the assistance of organisms that are alive. These products are even developed with the help of live drug materials that have been obtained from live organisms through the method of recombinant DNA or other methods that all in the category of controlling gene expressions. These products have been approved by the drug administrators and are developed through continuous analysis that is...
4 Pages(1000 words)Essay
Biosmilars
...BIOSIMILARS al Affiliation) Introduction EMA determined that the approach used for generic marketing izations is not scientifically appropriate for biologics, the guideline outlines a new approach for biosimilars The overall aim of this guideline is to establish general principles that enable applicants for a development program that establishes comparability while ensuring that the previously proven safety and efficacy of the drug is conserved ( Murray, 2007). General requirements in UK (MHRA) have been structured with the application being able to contain information-demonstrating biosimilarity on data that is derived from analytical studies showing that the biological product is...
4 Pages(1000 words)Essay
Sector/Cluster: network relationship with clients, suppliers, allies
2 Pages(500 words)Essay
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Let us find you another Research Paper on topic Biosimilar for FREE!
logo footer
Contact us:
+16312120006
Contact Us Now
FREE Mobile Apps:
  • StudentShare App Store
  • StudentShare Google play
  • About StudentShare
  • Testimonials
  • FAQ
  • Blog
  • Free Essays
  • New Essays
  • Essays
  • Miscellaneous
  • The Newest Essay Topics
  • Index samples by all dates
Join us:
Contact Us